Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
InMode Community
NasdaqGS:INMD Community
3
Narratives
written by author
1
Comments
on narratives written by author
88
Fair Values set
on narratives written by author
Create a narrative
InMode
Popular
Undervalued
Overvalued
Community Investing Ideas
InMode
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
US Regulatory Pressures Will Squeeze Margins Amid Global Tariffs
Key Takeaways Rising regulatory and labor costs, alongside public skepticism, threaten profitability and sustained demand for the company’s aesthetic treatment systems. Competitive pressures and dependence on international markets increase pricing, revenue, and margin volatility.
View narrative
US$14.00
FV
5.1% overvalued
intrinsic discount
-0.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
InMode
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Wellness Platform Will Diversify Offerings Yet Incur Cost Pressures
Key Takeaways InMode's international expansion and new platform for the wellness market are strategies to drive future revenue growth and offset U.S. challenges. Ongoing share repurchases and a strong balance sheet suggest a focus on increasing shareholder value and strategic growth opportunities through M&A.
View narrative
US$17.05
FV
13.7% undervalued
intrinsic discount
1.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
42
users have followed this narrative
5 days ago
author updated this narrative
InMode
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Global Aesthetic Trends Will Expand Markets Despite Tariff Concerns
Key Takeaways Expansion into international and underpenetrated markets, combined with ongoing product innovation, strengthens InMode’s position in the growing non-surgical aesthetic sector. Commitment to R&D and salesforce investment supports sustained growth and margin recovery as economic conditions and consumer confidence improve.
View narrative
US$24.00
FV
38.7% undervalued
intrinsic discount
5.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
INMD
INMD
InMode
Your Fair Value
US$
Current Price
US$14.72
4.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
474m
2015
2018
2021
2024
2025
2027
2030
Revenue US$441.5m
Earnings US$197.8m
Advanced
Set Fair Value